Genes linking Alzheimer's and Down syndrome discovered

June 25, 2018, The Francis Crick Institute
Credit: CC0 Public Domain

Scientists are a step closer to understanding which genes are responsible for early onset Alzheimer's disease in people with Down syndrome, thanks to a new study led by researchers at the Francis Crick Institute and UCL along with an international group of collaborators.

The findings could pave the way for future medicines to prevent the disease in these individuals, and provide insights into the mechanisms that cause dementia in the general population.

Around 1 in 800 people are born with Down syndrome, which arises in people carrying an extra copy of chromosome 21. By the time they reach their 60s, around two thirds of those with Down syndrome will have early onset Alzheimer's.

The high rates of Alzheimer's in people with Down syndrome were previously thought to be caused by a particular gene on chromosome 21 called APP. Chromosome 21 contains 231 , but APP was the prime suspect because it produces amyloid precursor proteins. These are involved in generating amyloid beta proteins, which build up in the brain in Alzheimer's patients.

In this study, published in the journal Brain, researchers found that extra copies of other genes on chromosome 21 increase Alzheimer's-like brain pathology and cognitive impairments in a mouse model of Down syndrome.

Dr. Frances Wiseman, Senior Research Fellow at UCL, and first author of this study, said: "We've shown for the first time that genes other than APP are playing a role in early-onset Alzheimer's disease in our model of Down Syndrome. Identifying what these genes are, and what pathways are involved in the earliest stages of neurodegeneration, could help us to one day intervene with these pathways to prevent the disease in people with Down syndrome."

The team compared that produce APP amyloid protein with, and without, the presence of human chromosome 21, to tease apart the contributions of APP and other genes in Alzheimer's disease.

They found that mice with an extra copy of all the genes on chromosome 21 had more signs of Alzheimer's disease than mice without. The mice with extra copies of all genes on chromosome 21 had greater levels of amyloid beta and more protein clumps or 'plaques' inside part of the brain that controls memory, and performed worse on memory tests.

The team then looked at what was causing the increased build-up of amyloid-beta and plaques in the brains of mice with of all the genes on human chromosome 21. They found that these mice produced more of a particular type of amyloid beta protein that is more prone to forming clumps.

Dr. Victor Tybulewicz, Group Leader at the Francis Crick Institute and co-senior author of the paper, said: "Down syndrome has historically been very difficult to model in a mouse, because the genes that we have on chromosome 21 are spread across three different in mice. Only after years of refining our mouse models can we study the earliest stages of Alzheimer's, and other diseases, in the context of Down syndrome."

Elizabeth Fisher, Professor of Neurogenetics at UCL, and co-senior author of the paper, added: "Although we're looking at Alzheimer's disease through the lens of Down , this international collaboration provides insight into the earliest stages of disease progression, which may be applicable to modulating Alzheimer's in the general population."

Explore further: Mutation discovered to protect against Alzheimer's disease in mice

More information: Brain (2018). DOI: 10.1093/brain/awy159

Related Stories

Mutation discovered to protect against Alzheimer's disease in mice

May 16, 2018
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific ...

New insight on why people with Down syndrome invariably develop Alzheimer's disease

October 23, 2014
A new study by researchers at Sanford-Burnham Medical Research Institute reveals the process that leads to changes in the brains of individuals with Down syndrome—the same changes that cause dementia in Alzheimer's patients. ...

Clinical trial investigates Alzheimer's disease drug in people with Down syndrome

May 31, 2017
A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer's disease supports further investigation of its potential. Results of the four-week trial of scyllo-inositol, ...

Studying Down syndrome might help us understand Alzheimer's disease better

May 5, 2015
Alzheimer's disease is the most common form of dementia in older adults. At the moment there is no cure, but many clinicians feel that the earlier one is diagnosed, the better the possibilities are for treatment or slowing ...

Researchers use imaging technique to predict dementia status in adults with down syndrome

August 10, 2016
Researchers at the University of Kentucky Sanders-Brown Center on Aging found that magnetic resonance spectroscopy (MRS), a noninvasive imaging technique, might help distinguish between people with Down syndrome who have ...

Down syndrome research untangles therapeutic possibilities for Alzheimer's

September 17, 2015
More than five million Americans are living with Alzheimer's disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients ...

Recommended for you

New Tourette disorder genes come to light

September 25, 2018
In the largest DNA sequencing study of Tourette Disorder (TD) to date, UC San Francisco researchers and their collaborators have unearthed new data suggesting a potential role for disruptions in cell polarity in the development ...

Genetic determinants of telomere length in African American youth

September 25, 2018
Telomeres are DNA-protein structures that play a vital role in maintaining DNA stability and integrity. Telomere length (TL) is an important biomarker of aging and overall health, but TL has been mostly studied in adult populations ...

Genetic testing: Not a one-and-done deal

September 25, 2018
Genetic testing can play a substantial role in medical management by uncovering changes in genes that are associated with an increased risk for hereditary cancers. A new research study from investigators at UT Southwestern ...

Exercise may delay cognitive decline in people with rare Alzheimer's disease

September 25, 2018
For individuals carrying a genetic mutation that causes Alzheimer's disease, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of Alzheimer's disease brain changes and may ...

A biomarker in the brain's circulation system may be Alzheimer's earliest warning

September 24, 2018
USC scientists say Alzheimer's could be diagnosed earlier if scientists focus on an early warning within the brain's circulation system.

Thousands of unknown DNA changes in the developing brain revealed by machine learning

September 24, 2018
Unlike most cells in the rest of our body, the DNA (the genome) in each of our brain cells is not the same: it varies from cell to cell, caused by somatic changes. This could explain many mysteries—from the cause of Alzheimer's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.